GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » ACI Formulations Ltd (DHA:ACIFORMULA) » Definitions » Cash Flow from Financing

ACI Formulations (DHA:ACIFORMULA) Cash Flow from Financing : BDT-890 Mil (TTM As of Mar. 2024)


View and export this data going back to 2008. Start your Free Trial

What is ACI Formulations Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Mar. 2024, ACI Formulations paid BDT0 Mil more to buy back shares than it received from issuing new shares. It spent BDT32 Mil paying down its debt. It paid BDT0 Mil more to buy back preferred shares than it received from issuing preferred shares. It spent BDT112 Mil paying cash dividends to shareholders. It received BDT0 Mil on other financial activities. In all, ACI Formulations spent BDT143 Mil on financial activities for the three months ended in Mar. 2024.


ACI Formulations Cash Flow from Financing Historical Data

The historical data trend for ACI Formulations's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ACI Formulations Cash Flow from Financing Chart

ACI Formulations Annual Data
Trend Dec13 Dec14 Dec15 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 557.26 -627.29 -678.98 -284.31 49.55

ACI Formulations Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -322.13 -439.38 -237.62 -67.00 -146.44

ACI Formulations Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

ACI Formulations's Cash from Financing for the fiscal year that ended in Jun. 2023 is calculated as:

ACI Formulations's Cash from Financing for the quarter that ended in Mar. 2024 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT-890 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ACI Formulations  (DHA:ACIFORMULA) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

ACI Formulations's issuance of stock for the three months ended in Mar. 2024 was BDT0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

ACI Formulations's repurchase of stock for the three months ended in Mar. 2024 was BDT0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

ACI Formulations's net issuance of debt for the three months ended in Mar. 2024 was BDT-32 Mil. ACI Formulations spent BDT32 Mil paying down its debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

ACI Formulations's net issuance of preferred for the three months ended in Mar. 2024 was BDT0 Mil. ACI Formulations paid BDT0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

ACI Formulations's cash flow for dividends for the three months ended in Mar. 2024 was BDT-112 Mil. ACI Formulations spent BDT112 Mil paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

ACI Formulations's other financing for the three months ended in Mar. 2024 was BDT0 Mil. ACI Formulations received BDT0 Mil on other financial activities.


ACI Formulations Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of ACI Formulations's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


ACI Formulations (DHA:ACIFORMULA) Business Description

Traded in Other Exchanges
N/A
Address
ACI Centre, 245, Tejgaon Industrial Area, Dhaka, BGD, 1208
ACI Formulations Ltd is an agricultural chemicals manufacturer. The principal activities of the company are manufacturing and marketing a number of agrochemical and consumer products. The company has structured its operations into the following business segments - Crop Care and Public Health segment, which manufactures and sell crop care and public health products; Mosquito Coil segment is engaged in the manufacturing and selling of mosquito coil products; the Aerosol segment is engaged in the manufacturing and selling aerosol and air freshener products; and Paint segment which manufactures and sells paint products. It derives key revenue from the Crop Care and Public Health segment.

ACI Formulations (DHA:ACIFORMULA) Headlines

No Headlines